Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in STEMI Patients
NCT03699215Phase 3Unknown
- Sponsor
- Hospital Universitario de Canarias
- Start
- Nov 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Levosimendan with Placebo (2 arms). Primary endpoint: Size of acute myocardial infarction at 30 days. Status: unknown.
02
Drugs
levosimendan
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03699215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03699215.